Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Post by Ricnaton Jun 25, 2020 10:35pm

279 Views

Post# 31193479

Nothing to expect until end of July

Following anonymous this morning, I sold at .245$ this morning ! Intelligent move with 2k in my pocket !

I leave until end of July cause anonymous, CIBC and few others know that Real bad PP almost destroy the share price cause nothing can justify 0.35$ so far with a repurpose product !!!

of course, phase 2b/3 will create big speculation as usual !!! Hoping for the best to those who didn't play their hand after PP ! It is always the same in ventures... were PP is, anonymous is also !!!!

See you next month !!! GLTA

Bullboard Posts

Southern Ontario mineral processing operation receives green fund support